Literature DB >> 11349199

Comparative use and knowledge of preconceptional folic acid among Spanish- and English-speaking patient populations in Phoenix and Yuma, Arizona.

J H Perlow1.   

Abstract

OBJECTIVE: The goal of the study was to compare levels of use and knowledge regarding the importance of periconceptional folic acid intake among Spanish- and English-speaking patient populations. STUDY
DESIGN: A survey was distributed to 315 pregnant patients seeking care at Phoenix Perinatal Associates. English (n = 183) and Spanish (n = 132) language surveys were completed by patients over a 6-month period. Results were analyzed to determine the level of use and understanding in relation to the importance of periconceptional folic acid in the prevention of neural tube defects by primary language and educational level.
RESULTS: Fewer than 1 in 12 patients surveyed (7.9%) were aware of a specific association between folic acid intake and the prevention of neural tube defects. Thirty-five percent of Spanish-speaking patients and 56.3% of English-speaking patients (difference, P <.001) were aware of nonspecific benefits of vitamin intake and the prevention of congenital malformations. A mere 1.2% of women with <4 years of high school education were consuming a multivitamin supplement preconceptionally compared with 46% of those with any education beyond high school (P <.0001). Spanish-speaking patients were significantly less likely to be consuming a vitamin supplement preconceptionally when compared with English-speaking patients (3.7% vs 22.4%; P <.0001). Among the 25 patients who demonstrated a specific knowledge of the ability of folic acid intake to prevent neural tube defects, 92% were English speaking compared with 8% who were Spanish speaking (P <.0001).
CONCLUSIONS: There is a critical lack of use and understanding regarding the importance of periconceptional folic acid intake to prevent neural tube defects. Our Spanish-speaking population and those with less formal education appear particularly vulnerable to not benefiting from the advantages of periconceptional folic acid. Educational efforts at promoting knowledge and use of folic acid need to incorporate strategies addressing the Spanish-speaking population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349199     DOI: 10.1067/mob.2001.112974

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Correlates of intake of folic acid-containing supplements among pregnant women.

Authors:  S L Carmichael; G M Shaw; W Yang; C Laurent; A Herring; Marjorie H Royle; M Canfield
Journal:  Am J Obstet Gynecol       Date:  2006-01       Impact factor: 8.661

2.  The use of folic acid for the prevention of birth defects in Puerto Rico.

Authors:  Lourdes García-Fragoso; Inés García-García; Cynthia E Rivera
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

3.  Folic acid and human reproduction-ten important issues for clinicians.

Authors:  Beth Dunlap; Kantha Shelke; Shala A Salem; Louis G Keith
Journal:  J Exp Clin Assist Reprod       Date:  2011-08-10

4.  Health care provider knowledge and practices regarding folic acid, United States, 2002-2003.

Authors:  Jennifer L Williams; Stephen M Abelman; Elizabeth M Fassett; Cheryl E Stone; Joann R Petrini; Karla Damus; Joseph Mulinare
Journal:  Matern Child Health J       Date:  2006-09

5.  Preconception healthcare: what women know and believe.

Authors:  Keith A Frey; Julia A Files
Journal:  Matern Child Health J       Date:  2006-06-08

6.  Knowledge, attitude and practice of physicians regarding periconceptional folic acid for women at low risk of a neural tube defect affected pregnancy.

Authors:  Liana Arielle Mida; Vincent Della Zazzera; Bénédicte Fontaine-Bisson
Journal:  Prev Med Rep       Date:  2021-02-06

7.  Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study.

Authors:  Hazel M Inskip; Sarah R Crozier; Keith M Godfrey; Sharon E Borland; Cyrus Cooper; Siân M Robinson
Journal:  BMJ       Date:  2009-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.